Association of CD14 promoter polymorphism with otitis media and pneumococcal vaccine responses.

Full Abstract

Innate immunity is of particular importance for protection against infection during early life, when adaptive immune responses are immature. CD14 plays key roles in innate immunity, including in defense against pathogens associated with otitis media, a major pediatric health care issue. The T allele of the CD14 C-159T polymorphism has been associated with increased serum CD14 levels. Our objective was to investigate the hypothesis that the CD14 C-159T allele is protective against recurrent acute otitis media in children. The association between the CD14 promoter genotype and the number of acute otitis media episodes was evaluated both retrospectively and prospectively in a cohort of 300 children. Serotype-specific immunoglobulin G (IgG) antibody responses after pneumococcal vaccinations were examined according to CD14 genotype to compare immune responsiveness across genotypes. An age-dependent association was found:
compared with that for CC homozygotes aged between 12 to 24 months, TT homozygotes had fewer episodes of acute otitis media (79 versus 41%, respectively; P = 0.004); this relationship was absent in older children. Additionally, TT homozygotes showed higher serotype-specific anti-pneumococcal IgG antibody levels. Our data suggest that genetic variation in CD14, a molecule at the interface of innate and adaptive immune responses, plays a key role in the defense against middle ear disease in childhood and in pneumococcal vaccine responsiveness. These findings are likely to be important to these and other immune-mediated outcomes in early life.

Learn Faster Today Improve your study skills

Author information

Author/s: Wiertsema, S P (SP); Khoo, S-K (SK); Baynam, G (G); Veenhoven, R H (RH); Laing, I A (IA); Zielhuis, G A (GA); Rijkers, G T (GT); Goldblatt, J (J); Lesouëf, P N (PN); Sanders, E A M (EA);

Affiliation: Department of Pediatric Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: Clinical and vaccine immunology : CVI (Clin Vaccine Immunol), published in United States. (Language: eng)

Reference: 2006-Aug; vol 13 (issue 8) : pp 892-7

Dates: Created 2006/08/08; Completed 2006/12/05; Revised 2008/11/21;

PMID: 16893989, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

ErratumIn: Clin Vaccine Immunol. 2006 Dec;13(12):1375.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Immunoglobulins - blood
Infant
Male
Otitis Media - genetics; pathology; prevention & control
Pneumococcal Vaccines - therapeutic use
Polymorphism, Genetic
Promoter Regions, Genetic
Prospective Studies
Recurrence - prevention & control
Retrospective Studies

Associated Chemicals: Antigens, CD14 (0) ; Immunoglobulins (0) ; Pneumococcal Vaccines (0)

These are the highest related articles currently in the database:

See 100+ related articles.